Finally some good news. This has been a tough ride downhill, we needed it. TR440000 has been kind to me by not telling us, "I told you so" all the way down. We are still waiting the news on the detail of the Elagolix trial, which should be really meaningful to the stock price. I think we may get the Uterine Fibroids update next quarter.